Literature DB >> 10974560

Characterization of the human NTAK gene structure and distribution of the isoforms for rat NTAK mRNA.

K Yamada1, N Ichino, K Nishii, H Sawada, S Higashiyama, H Ishiguro, T Nagatsu.   

Abstract

NTAK (neural- and thymus-derived activator for the ErbB kinase, neuregulin-2) is a novel member of the epidermal growth factor (EGF) family. We have isolated and characterized the human NTAK gene, comprising 12 exons spanning in excess of 55 kilobases (kb). The 7. 0kb long mRNA of the human NTAK gene was expressed in the human neuroblastoma SK-N-SH cell line with two alternative isoforms detected. Furthermore, six isoforms have been identified from rat brain and PC-12 cells. Although the alpha isoform of the NTAK gene was found to be expressed in all tissues including brain, the beta isoform was expressed only in rat brain tissues. Potential regulatory regions included consensus binding sites for AP-2, TF-IIIA, Sp-1, and YY-1 located in the 5'-flanking region of the NTAK gene.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10974560     DOI: 10.1016/s0378-1119(00)00309-7

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

Review 1.  Multiple personalities of neuregulin gene family members.

Authors:  D A Talmage; L W Role
Journal:  J Comp Neurol       Date:  2004-04-26       Impact factor: 3.215

Review 2.  Signalling between microvascular endothelium and cardiomyocytes through neuregulin.

Authors:  Emily M Parodi; Bernhard Kuhn
Journal:  Cardiovasc Res       Date:  2014-01-29       Impact factor: 10.787

3.  Generation and characterization of neuregulin-2-deficient mice.

Authors:  Joanne M Britto; Sherralee Lukehurst; Renae Weller; Chris Fraser; Yubin Qiu; Paul Hertzog; Samantha J Busfield
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

Review 4.  The neuregulin family of genes and their multiple splice variants in breast cancer.

Authors:  Nandini V L Hayes; William J Gullick
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-04-15       Impact factor: 2.673

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.